EFTA Document EFTA01457557

Deutsche Bank Markets Research Rating Hold Europe United Kingdom Pharmaceuticals Pharmaceuticals Company GlaxoSmithKline 08.1L GSK LN EN:mango r:cto/ LSE GSK Updating for margin reset/dilution - smooth execution now critical ineentol eecre Fats out cfedrble !date:. nbvi all about e>ecuhon GSK's 1O results were all but overshadowed by its decision to forgo the planned f4bn B share scheme in return for a longer term commitment to a maintained dividend. Although we view managemen